Trials / Conditions / Recurrent Mucosal Melanoma
Recurrent Mucosal Melanoma
3 registered clinical trials studyying Recurrent Mucosal Melanoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery NCT05111574 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positiv NCT05098210 | Fred Hutchinson Cancer Center | Phase 1 |
| Active Not Recruiting | Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizuma NCT02506153 | National Cancer Institute (NCI) | Phase 3 |